AB Science S.A.

The European Medicines Agency hit a 15-year high for positive drug recommendations in 2024, with 114 new medicines gaining a positive opinion for regulatory approval across the EU from its human medic

The European Medicines Agency is this week deciding whether to recommend pan-EU marketing authorization for a number of new drugs, including odronextamab, Regeneron Pharmaceuticals ’ investigational

At long last, AB Science has some good news to share about its lead candidate, masitinib, after the French biotech announced positive top-line late-stage results for the drug in severe asthma. The P

The tracker below provides information on accelerated assessment requests for planned marketing authorization applications (MAAs) that are known to have come before the European Medicines Agency’s Com